what is the difference between dpp-4 inhibitors and glp-1 analogs Mechanism of action for GIP, analogues DPP4 in Differences between GLP-1 receptor agonists

The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble

This triple-agonist approach not only enhances satiety and insulin sensitivity but also increases energy expenditure, offering a comprehensive strategy for metabolic health restoration

Context for confounding and differential diagnosis: SGLT2 inhibitors are known to increase genital mycotic infection risk, including vulvovaginal candidiasis, and real-world studies demonstrate clinically significant vaginitis incidence in usersmaking SGLT2 exposure a critical confounder when patients attribute yeast infections to semaglutide

Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: A randomized, open-label trial

Hormonal Balance Weight gain or difficulty losing weight can be tied to hormonal imbalances beyond blood sugar (e.g., thyroid issues or cortisol levels)